Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCSF
Dates
study started
completion around
Principal Investigator
by Lee-lynn Chen, MD (ucsf)Matthieu Legrand, MD (ucsf)Jeremy Juang, MD (ucsf)Jennifer Woodbury, MD (ucsf)
Headshot of Jeremy Juang
Jeremy Juang

Description

Summary

The investigators will conduct a 12,500-patient randomized multi-center trial to determine (i) which general anesthesia technique yields superior patient recovery experiences in any of three surgical categories ((a) major inpatient surgery, (b) minor inpatient surgery, (c) outpatient surgery) and (ii) whether TIVA confers no more than a small (0.2 %) increased risk of intraoperative awareness than INVA in patients undergoing both outpatient and inpatient surgeries

Keywords

Surgery-Complications, Anesthesia Complication, Anesthesia Awareness, Anesthesia, Surgery, Quality of Life, Pain, Postoperative, Anesthesia Morbidity, Postoperative Pain, Intraoperative Awareness, Propofol, Anesthetics, Anesthetic technique Propofol TIVA, Anesthetic technique inhaled agent, Propofol total intravenous anesthesia (TIVA), inhaled volatile general anesthesia (INVA)

Eligibility

Locations

  • University of California San Francisco accepting new patients
    San Francisco California 94143 United States
  • Stanford University not yet accepting patients
    Stanford California 94305 United States
  • Oregon Health and Sciences University accepting new patients
    Portland Oregon 97239 United States

Lead Scientists at University of California Health

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Washington University School of Medicine
ID
NCT05991453
Study Type
Interventional
Participants
Expecting 12500 study participants
Last Updated